{"id":495610,"date":"2020-07-13T16:36:01","date_gmt":"2020-07-13T16:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=495610"},"modified":"2020-07-13T16:36:01","modified_gmt":"2020-07-13T16:36:01","slug":"global-hydroxychloroquine-market-value-expected-to-reach-12-billion-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-hydroxychloroquine-market-value-expected-to-reach-12-billion-by-2023_495610.html","title":{"rendered":"Global Hydroxychloroquine Market Value Expected To Reach $1.2 Billion By 2023"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1594638182.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Global Hydroxychloroquine Market Value Expected To Reach $1.2 Billion By 2023\" src=\"https:\/\/www.abnewswire.com\/uploads\/1594638182.jpeg\" alt=\"Global Hydroxychloroquine Market Value Expected To Reach $1.2 Billion By 2023\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Hydroxychloroquine Market Global Report 2020-30: Covid 19 Implications And Growth<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Bayer Is One Of The Largest Players In The Hydroxychloroquine Market, According To The Business Research Company\u2019s Hydroxychloroquine Market Global Report 2020-30: COVID-19 Implications And Growth. (Companies Covered: Bayer AG, Dr. Reddy`s Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Wallace Pharma, Teva, Mylan, Novartis, Intas Pharmaceuticals, Lupin Limited, Shanghai Zhongxisanwei, Torrent Pharma, BSE healthcare, HIKMA, Sandoz, IPCA Laboratories, Cipla Limited, Shanghai Pharma)<\/div>\n<p style=\"text-align: justify;\">The global hydroxychloroquine market is expected to grow from $718 million in 2019 to $980.1 million in 2020 at a rate of 36.5%. The growth is mainly attributed to the COVID-19 outbreak and the urgent need to treat the growing number of cases. With no effective therapeutics discovered so far, some of the existing drugs, including hydroxychloroquine, have been repurposed for COVID-19 infection treatment. Hydroxychloroquine is found to be effective against coronavirus in laboratory studies and in-vivo studies. The market is then expected to stabilize and reach $1,281.3 million in 2023 at a rate of 9.3%.<\/p>\n<h4 style=\"text-align: justify;\"><strong>Read More On The Global Hydroxychloroquine Market Report At &#8211;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.thebusinessresearchcompany.com\/report\/hydroxychloroquine-market-global-report-2020-30-covid-19-implications-and-growth\">https:\/\/www.thebusinessresearchcompany.com\/report\/hydroxychloroquine-market-global-report-2020-30-covid-19-implications-and-growth<\/a><\/h4>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The hydroxychloroquine market consists of revenue generated by establishments through the sales of hydroxychloroquine drugs. It is an antimalarial drug used for the treatment of malaria, systemic lupus erythematosus (SLE), and rheumatoid arthritis. Hydroxychloroquine is used in combination with antibiotic azithromycin as a potential treatment for COVID-19.<\/p>\n<h4 style=\"text-align: justify;\"><strong>Global Hydroxychloroquine Market Segmentation &ndash; <\/strong><\/h4>\n<p style=\"text-align: justify;\">The hydroxychloroquine market covered in this report is segmented <br \/> <strong>1) By Drug Activity:<\/strong> Anti-Malarial, Anti-Rheumatic, Lupus Suppressant, Anti COVID19, Others <br \/> <strong>2) By Formulation:<\/strong> Tablets, Injection <br \/> <strong>3) By Application:<\/strong> Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, Others <br \/> <strong>4) By Distribution Channel:<\/strong> Hospital Pharmacy, Online Pharmacy, Specialty Drug Stores, Retail Pharmacy<\/p>\n<h4 style=\"text-align: justify;\"><strong>Global Hydroxychloroquine Market Driver &ndash; <\/strong><\/h4>\n<p style=\"text-align: justify;\">The increasing number of coronavirus cases has increased the demand for hydroxychloroquine in 2020. The demand for hydroxychloroquine is growing, which is attributed to its use in the treatment of COVID-19 patients and in the ongoing clinical trials. The US Food and Drug Administration has authorized emergency use of hydroxychloroquine for the treatment of COVID-19 patients in the hospital or enrolled by clinical trials. Major players operating in the market are undertaking various strategic initiatives such as increasing production capacity and the expansion of manufacturing plants to meet the augmented global demand.<\/p>\n<h4 style=\"text-align: justify;\"><strong>Request For A Sample Of The Global Hydroxychloroquine Market Report At &#8211;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=3235&amp;type=smp\">https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=3235&amp;type=smp<\/a><\/h4>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Few Points From The Global Hydroxychloroquine<\/strong><strong> Market TOC <br \/> <\/strong>1. Executive Summary<strong><br \/> <\/strong>2. Hydroxychloroquine Market Characteristics<strong><br \/> <\/strong>3. Hydroxychloroquine Market Size And Growth<strong><br \/> <\/strong>3.1. Global Hydroxychloroquine Historic Market, 2015 &#8211; 2019, $ Billion<strong><br \/> <\/strong>3.1.1. Drivers Of The Market<br \/>3.1.2. Restraints On The Market<br \/>3.2. Global Hydroxychloroquine Forecast Market, 2019 &#8211; 2023F, 2025F, 2030F, $ Billion<br \/>3.2.1. Drivers Of The Market<br \/>3.2.2. Restraints On the Market<br \/>4. Hydroxychloroquine Market Segmentation<br \/>4.1. Global Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<br \/>Anti-Malarial Drug<br \/>Anti-Rheumatic Drug<br \/>Lupus Suppressant Drug<br \/>Anti COVID19 Drug<br \/>Others<br \/>4.2. Global Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<br \/>Tablets<br \/>Injection<br \/>4.3. Global Hydroxychloroquine Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<br \/>Malaria<br \/>Rheumatoid arthritis<br \/>Lupus Erythematosus<br \/>COVID-19<br \/>Others<br \/>4.4. Global Hydroxychloroquine Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<br \/>Hospital pharmacy<br \/>Online pharmacy<br \/>Specialty drug stores<br \/>Retail pharmacy<br \/>5. Hydroxychloroquine Market Regional And Country Analysis<br \/>5.1. Global Hydroxychloroquine Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<br \/>5.2. Global Hydroxychloroquine Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<\/p>\n<p style=\"text-align: justify;\"><strong>Interested to know more about The Business Research Company?<br \/><\/strong>The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/thebusinessresearchcompany.com_43375.html\" rel=\"nofollow\">The Business Research Company<\/a><br \/><strong>Contact Person:<\/strong> Oliver Guirdham<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=global-hydroxychloroquine-market-value-expected-to-reach-12-billion-by-2023\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +44 20 7193 0708<br \/><strong>Address:<\/strong>1st Floor, Anshu Colors Building, Road Number 1   <br \/><strong>City:<\/strong> London<br \/><strong>State:<\/strong> Greater London<br \/><strong>Country:<\/strong> United Kingdom<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.thebusinessresearchcompany.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.thebusinessresearchcompany.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.thebusinessresearchcompany.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=global-hydroxychloroquine-market-value-expected-to-reach-12-billion-by-2023\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hydroxychloroquine Market Global Report 2020-30: Covid 19 Implications And Growth Bayer Is One Of The Largest Players In The Hydroxychloroquine Market, According To The Business Research Company\u2019s Hydroxychloroquine Market Global Report 2020-30: COVID-19 Implications And Growth. (Companies Covered: Bayer AG, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/global-hydroxychloroquine-market-value-expected-to-reach-12-billion-by-2023_495610.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,404,416],"tags":[],"class_list":["post-495610","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/495610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=495610"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/495610\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=495610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=495610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=495610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}